14 studies found for:    Ectodermal Dysplasia | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia
Condition: X-Linked Hypohidrotic Ectodermal Dysplasia
Intervention:
2 Recruiting Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
Condition: X-Linked Hypohidrotic Ectodermal Dysplasia
Intervention: Drug: EDI200
3 Recruiting Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002
Condition: X-linked Hypohidrotic Ectodermal Dysplasia
Intervention: Drug: EDI200
4 Recruiting Study of Selected X-linked Disorders: Goltz Syndrome
Conditions: Focal Dermal Hypoplasia (FDH);   Goltz Syndrome;   X Linked Disorders
Intervention:
5 Recruiting Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)
Condition: Aplasia Cutis Congenita
Intervention:
6 Recruiting Feasibility of Upright Bed Position in ARDS Patients
Conditions: Critical Illness;   Acute Respiratory Failure;   Adult Syndrome
Intervention: Other: Intervention Arm
7 Recruiting Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
Condition: Pachyonychia Congenita
Interventions: Drug: 1% sirolimus cream (TD201 1%);   Drug: placebo cream (vehicle control)
8 Not yet recruiting Simvastatin Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Intervention: Drug: Simvastatine
9 Recruiting Topical Sirolimus for Plantar Keratoderma in Adults With Pachyonychia Congenita (PC)
Conditions: Pachyonychia Congenita;   Plantar Keratoderma
Intervention: Drug: Topical Sirolimus
10 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
11 Recruiting Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
12 Recruiting Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Condition: Sturge Weber Syndrome
Intervention: Drug: Everolimus
13 Recruiting French National Cohort of Children With Port Wine Stain
Conditions: Port Wine Stain;   Klippel Trenaunay Syndrome;   Parkes Weber Syndrome
Intervention: Genetic: search for polymorphisms of RASA1 gene
14 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port Wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.

Indicates status has not been verified in more than two years